Management of Covid-19 Patients During Home Isolation

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04368923

Enrollment

Registered

2020-04-30

Start date

2020-03-15

Completion date

2020-06-23

Last updated

2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid 19

Brief summary

This study will be concerned with managing patients of Covid-19 while being home isolated.

Interventions

DEVICEOxygen Therapy

Patients receive oxygen therapy

PROCEDUREPhysical Therapy

Patients receive physical therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

21 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Patients with Covid-19 * American Society of Anesthesiologists (ASA) class I * \>= 21 years old * \<= 40 years old

Exclusion criteria

* ASA class II, class III or class IV

Design outcomes

Primary

Measure	Time frame
Arterial Blood Gases (ABG): Partial Pressure of Oxygen and Carbon Dioxide	48 hours
Arterial Blood Gases (ABG): Acidity Potential Hydrogen (pH)	48 hours

Secondary

Measure	Time frame
Vital Signs (Oxygen Saturation)	24 hours
Vital Signs (Temprature)	24 hours
Vital Signs (Blood Pressure)	24 hours
Vital Signs (Heart Rate)	24 hours
Vital Signs (Respiratory Rate)	24 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026